Use code: IMMUNE25 at Checkout to save 25% on Immune Support products

Blis Technologies Corporate Governance

Our Board

Geoff Plunket

Geoff Plunket - Deputy Chairman - Blis Probiotics

Geoff is currently a Dunedin based Professional Director and Consultant. Geoff is a Fellow of Chartered Accountants Australia and New Zealand, and a Member of the Institute of Directors. Geoff was invited to join the Blis Technologies Ltd Board in May 2018.

Geoff worked for Coopers & Lybrand (now PWC) and KPMG, in Dunedin and Birmingham, UK through the 1980’s before joining Port Otago Ltd in 1988, as Chief Financial Officer. Geoff spent the following 29 years with the Port Otago Group, before retiring in 2017. Geoff worked across the business in a variety of roles, culminating in appointment as CEO in 2004, a position he held until retirement.

Geoff brings significant experience in leading a large successful organization with expertise in logistics, managing international trading relationships, supply chain, human resource, health and safety and risk management. Geoff believes success comes from a focus on quality and delivering outstanding customer service.

Tony Balfour

Tony Balfour - Blis Probiotics
Deputy Chairman

Tony was appointed to the Board on 9 April 2020. He brings to the board strong governance experience following a successful executive career as an international marketing and brand management leader building consumer goods businesses globally.

Tony has a diverse background of international experience in driving FMCG through retail channels and e-commerce from the leadership roles he held for Nike Inc, Icebreaker, and Monster Worldwide. He holds directorships with The Warehouse, Les Mills International and Wayfare Ltd (trading as Real Journeys). Tony has previously been a director of Silver Fern Farms and Methven.

Barry Richardson

Independent non-executive director
Barry Richardson - Blis Probiotics

Barry Richardson began his career as a scientist at the NZ Dairy Research Institute before joining the NZ Dairy Board in 1985 as a Business Development Manager, undertaking roles in several biotechnology and nutritional Dairy Board joint venture companies.

Barry joined Tatua Co-Op Dairy Company in 1991 as General Manager, Tatua Biologics and was later appointed General Manager, International and Strategic Development commercialising value added dairy ingredients. He was appointed CEO of Westland Milk Products when the Company elected to be an independent exporter of dairy products in late 2001.

From 2006-2016 Barry was CEO of Blis Technologies Limited, through the period when the Company transitioned from a research company into a commercial entity.

Barry has a M.Sc. (Hons) in Biochemistry and a Ph.D. from Massey University. He is a past Fellow of the NZ Institute of Management and a Fellow of the NZ Institute of Food Science and Technology. He was awarded the JC Andrews award for distinction in Food Science and Technology in 2003.

Barry was appointed a director of Blis Technologies Ltd in 2018. His other professional role is a Director of CertusBio.

A P Offen

Independent non-executive director
Tony Offen - Chairman - Blis Probiotics

Tony Offen has been a Director of Blis Technologies Limited since May 2009 and is the current Chair. Through his Dunedin-based investment company, Edinburgh Securities Limited, Tony has experience as a director and shareholder of successful private companies, including in the commercial and industrial property sectors, FMCG business sectors nationally and internationally, and investment interests requiring venture and start-up capital.

Tony holds professional memberships with the Chartered Accountants Australia and New Zealand and is a Chartered Member of the NZ Institute of Directors. He is currently Acting Chair of the Governance Board of Brain Research New Zealand, a Centre of Research Excellence (CoRE) and until Dec-19 was an elected member of the National Council for the Neurological Foundation of NZ. Tony holds a B.Com. (Accounting) and B.A. (Philosophy) from University of Otago.

Dr. A Stewart

Independent non-executive director
Alison Stewart - Blis Probiotics

Dr. Stewart brings to the board governance and commercial research and development experience within the international biotechnology industry. Dr Stewart has held key executive leadership roles in New Zealand and US corporates and understands the drivers for successful commercialization of research.

Alison is an experienced research and innovation leader with expertise in microbe-based product development, patents, IP protection, new product pipeline and development of strategic partnerships with large international corporations.

Dr. Stewart is currently Chief Executive Officer of the Foundation for Arable Research and in previous roles has lead research centres across NZ, Australia, and the USA. Alison is a Distinguished Emeritus Professor from Lincoln University, NZ and was elected a Companion of the NZ Order of Merit in 2011 for her contributions to biology. Dr. A Stweart joined the Blis Technologies Ltd board on 28 September 2018

Tom Rönnlund

Non-executive director
Tom Rönnlund

Tom Rönnlund is currently the CEO of Probi AB, a world leading Swedish listed biotechnology company and substantial product holder of Blis Technologies. He holds a Master’s degree in Business Administration and Economics from Stockholm University.

Before joining Probi AB in January 2019, Tom served as CEO of Navamedic ASA, a listed Norwegian pharma and medtech company. Tom has more than 20 years experience working in the healthcare industry, and has held several positions in sales, marketing and general management at IQVIA and in international biopharmaceutical companies such as Bristol-Myers Squibb and Eli Lilly.

Aimee McCammon

Independent non-executive director

Aimee McCammon is CEO NZ of Augusto Group, an entertainment, advertising and technology company. She is an experienced strategist and brand builder with deep knowledge of consumer marketing. Her brand experience spans an array of New Zealand’s power brands including Whittaker’s, Toyota, Lotto, Tourism NZ and 42 Below.

Aimee was General Manager of Peter Jackson’s Park Road Post Production for three years, leading a world class team of Oscar winning creatives alongside digital and film laboratories. Over the past decade she has also held senior management roles at Assignment Group and Trade Me, following a successful career with the Saatchi & Saatchi network that spanned Wellington, Auckland and New York.

Aimee has a Bachelor of Commerce from Auckland University, and has completed leadership training at the Omnicom University in Shanghai. She is an independent director of Flick Electric, and an advisory board member for Pic’s Peanut Butter.

Our Senior Management Team

Brian Watson - CEO - Blis Probiotics

Brian Watson

Chief Executive Officer (CEO)
B Com (Marketing), B Ph Ed

Brian was appointed CEO of Blis Technologies in February 2016. He joined Blis following senior management roles with Fonterra and within the Pharmaceutical industry in New Zealand and overseas. Brian’s career has focused on general management, marketing and sales across healthcare, nutraceutical and nutrition industries. Brian has a track record of successfully launching global brands into new markets and leading change within organisations.

Richard Wingham - CFO - Blis Probiotics

Richard Wingham

Chief Financial Officer (CFO)
CA, BCom (Accounting)

Richard Wingham was appointed to the role of CFO for Blis Technologies in November 2017.  Richard is a Chartered Accountant with over 20 years experience, including various senior finance roles across the dairy FMCG, construction and health sectors. His skills cross over manufacturing, project management, information technology and strategic planning.

John Hale - CTO - Blis Probiotics

Dr John Hale

Chief Technology Officer (CTO)

John Hale did his PhD studying bacteriocins (BLIS) under the supervision of Professor John Tagg at the Department of Microbiology, University of Otago. He carried out post-doctoral research at the University of British Columbia (Vancouver, Canada) and Monash University School of Pharmacy (Melbourne, Australia) investigating the modes of action of antimicrobial peptides. Dr Hale joined Blis Technologies in 2011 and leads the Scientific Services team.

Frank Spiewack - Commercial Director - Blis Probiotics

Frank Spiewack

Commercial Director

Frank joined Blis Technologies in November 2019 and was confirmed as a member of the executive team in May 2020. Frank has a strong background developing international markets having worked as Vice President Global Sales and Marketing for Alchemy Equipment and Manager Distributor and Emerging Markets for Icebreaker.

Jennifer Walker - eCommerce and Marketing Director - BLIS Probiotics

Jennifer Walker

eCommerce and Marketing Director

Jennifer started in February 2022 having extensive global marketing experience within consumer and wellness sectors
in both start-ups and larger corporates. Jennifer has a strong experience base across eCommerce, brand and retail marketing, having worked for international brands such as Puma and corporates focused on the health and wellness sector.